Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Guangzhou Jihua Medical Equipment Co., Ltd., established on 2000-05-10, Business scope includes medical diagnosis,Monitoring and treatment equipment manufacturing;Licensed medical device business(apply<Medical device operating enterprise license>medical device",Including the third class of medical devices and need to apply<Medical device operating enterprise license>Class II medical devices that can only be operated);software development;Import and export(Excluding franchised products);Technology Import and Export;

Fujimori Kogyo Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical packaging, electronics and optoelectronics films, daily commodities and food packaging and pouches. It operates through the following segments: Life Science, Information Electronics, and Building Materials. The Life Science segment includes pouches, foldable plastic liquid containers, and packaging materials for pharmaceuticals, food, and life products. The Information Electronics segment consists of protection films for optical applications, interlayer insulating films, and release films. The Building Materials segment manufactures and sells concrete formwork, slab materials, formwork tubes, waterproof sheets for tunnels, materials for tunnel excavation use, airtight doors, chimney lining materials, and surface protective materials. The company was founded on April 1, 1914 and is headquartered in Tokyo, Japan.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Suzhou Kangmeile Biotechnology Co., Ltd., established on 2016-05-26, The scope of business includes technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services;Pharmaceutical business and research and development of biopharmaceutical products,Sales and related technical services(The operating permit),Cell Storage Service(National law,Administrative regulations,Projects prohibited by the State Council shall not be operated),Manufacturing and sales of beauty products,Invest in medical projects,Technical consultation for medical product declaration,Import and export,Technology Import and Export.(Projects subject to approval by relevant departments according to law,Business activities can only be carried out after approval) .

The First Hospital of Jilin University, part of Jilin University, is a company headquartered in Changchun, China. The firm owns and operates hospital.

Chongqing Wangye Pharmaceutical Research Co., Ltd., established on 2020-03-12, Business scope includes licensed projects:pharmaceutical production,Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Yangpu District Shidong Hospital is a Chinese private company located in Shanghai. The firm owns and operates hospital.

Shanghai No.1 Biochem & Pharm Co. Ltd., a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., is a Chinese company located in Shanghai. The firm manufactures pharmaceuticals. It was acquired by Shanghai Pharmaceuticals Holding Co., Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. on February 03, 2010 for $118.49 million.

Taiyuan Iron and Steel (Group) Co., Ltd., established on 1997-12-05, Business scope includes smelting,processing,manufacture,Sales of steel,billet,Steel ingot,pig iron,roll,ferroalloy,Coking products,refractory material,Minerals,metal products,Raw materials for steel production,building materials,electronic product,Metallurgical electromechanical equipment,spare parts;Technical Services;road freight transport;construction work,construction project,engineering design,construction;food business,accommodation service,Catering, hotels and other service industries;Contract overseas projects in this industry and domestic international bidding projects and the required equipment,Import and export of materials and spare parts;Foreign dispatch of labor personnel for engineering production and service in this industry;(Except for projects subject to special examination and approval by the state)to the mining industry,manufacturing,construction industry,real estate,Technical Services and Geological Exploration Industry,Transportation and warehousing,electricity,Production and supply of gas and water,Investment in information transmission computer software.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Datongmeng Pharmaceutical Co., Ltd., established on 2013-03-22, The business scope includes freeze-dried powder injection,small volume injection(non-terminal sterilized)production,Technology research and development of drugs and medical devices,technical consulting,technology transfer,Class I medical device production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)